<DOC>
	<DOCNO>NCT01810796</DOCNO>
	<brief_summary>Working hypothesis aim : 1 ) To explore pathophysiology postoperative troponin elevation 2 ) whether ranolazine , new anti-ischemic drug effect blood pressure heart rate , prevents postoperative myocardial injury .</brief_summary>
	<brief_title>Pathophysiology Prevention Perioperative Myocardial Injury : A Prospective Randomized Controlled Trial</brief_title>
	<detailed_description>High-risk patient undergo non cardiac surgery randomize receive either Ranolazine placebo perioperatively troponin measure first 3 day surgery .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>All patient age 18 , undergo major surgery require least 24 hour ( overnight ) stay post anesthesia care unit ( PACU ) intensive care unit ( ICU ) , either know history CAD least 3 follow Revised Cardiac Risk Index ( RCRI ) criteria29F17 : 1 ) highrisk type surgery , 2 ) history ischemic heart disease , 3 ) history congestive heart failure , 4 ) history cerebrovascular disease , 5 ) diabetes mellitus , 6 ) renal failure ( creatinine &gt; 2mg/ml ) . Pregnancy , LV ejection fraction â‰¤35 % , patient severe valvular disease , patient poor echocardiographic image , patient swallow pill surgery , refusal participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>